Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability II: Stability of a vaccine

被引:74
作者
Abdul-Fattah, Ahmad M.
Truong-Le, Vu
Yee, Luisa
Pan, Emilie
Ao, Yi
Kalonia, Devendra S.
Pikal, Michael J. [1 ]
机构
[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[2] MedImmune Vaccines, Formulat Dev, Mountain View, CA 94043 USA
[3] Amgen Inc, Drug Prod & Device Dev, Thousand Oaks, CA USA
关键词
drying vaccines; electron spectroscopy for chemical analysis (ESCA); glass transition temperature (T-g); parainfluenza virus; specific surface area; surface coverage; total surface accumulation; vaccine stability;
D O I
10.1007/s11095-006-9191-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To investigate the impact of drying method on the storage stability of dried vaccine formulations. A sucrose-based formulation of a live attenuated virus vaccine of a parainfluenza strain, with and without surfactant, was dried from by different methods; freeze drying, spray drying and foam drying. Dried powders were characterized by differential scanning calorimetry, specific surface area (SSA) analysis and by electron spectroscopy for chemical analysis (ESCA) to evaluate vaccine surface coverage in the dried formulations. Dried formulations were subjected to storage stability studies at 4, 25 and 37 degrees C. The vaccine was assayed initially and at different time points to measure virus-cell infectivity, and the degradation rate constant of the vaccine in different dried preparations was determined. SSA was highest with the spray dried preparation without surfactant (similar to 2.8 m(2)/g) and lowest in the foam dried preparations (with or without surfactant) (similar to 0.1 m(2)/g). Vaccine surface coverage was estimated based on ESCA measurements of nitrogen content. It was predicted to be highest in the spray dried preparation without surfactant and lowest in the foam with surfactant. Stability studies conducted at 25 degrees C and 37 degrees C showed that the vaccine was most stable in the foam dried preparation with surfactant and least stable in spray dried preparations without surfactant and in all freeze dried preparations regardless of the presence of surfactant. Addition of surfactant did lower the SSA and vaccine surface coverage in freeze dried preparations but still did not improve storage stability. In drying methods that did not involve a freezing step, good storage stability of Medi 534 vaccine in the dried form was found with low SSA and low vaccine surface accumulation, both of which integrate into low fraction of vaccine at the surface. Ice appears to be a major destabilizing influence.
引用
收藏
页码:715 / 727
页数:13
相关论文
共 60 条
[51]   Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying [J].
Tang, XL ;
Pikal, MJ .
PHARMACEUTICAL RESEARCH, 2005, 22 (07) :1176-1185
[52]  
TRUDEL PPA, 1993, METHODS TECHNIQUES V, P30
[53]  
TRUONGLE V, 2003, PRESERVATION BIOACTI
[54]  
TRUONGLE V, 2005, HIGH PRESSURE SPRAY
[55]   Surface adsorption of recombinant human interferon-γ in lyophilized and spray-lyophilized formulations [J].
Webb, SD ;
Golledge, SL ;
Cleland, JL ;
Carpenter, JF ;
Randolph, TW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (06) :1474-1487
[56]  
White DO, 1987, MED VIROLOGY
[57]   Xerovac:: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines [J].
Worrall, EE ;
Litamoi, JK ;
Seck, BM ;
Ayelet, G .
VACCINE, 2000, 19 (7-8) :834-839
[58]  
YIN LI, 1978, INSTRUMENTAL ANAL, P418
[59]   Usefulness of the Kohlrausclh-Williams-Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature [J].
Yoshioka, S ;
Aso, Y ;
Kojima, S .
PHARMACEUTICAL RESEARCH, 2001, 18 (03) :256-260
[60]   Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization [J].
Zhai, SL ;
Hansen, RK ;
Taylor, R ;
Skepper, JN ;
Sanches, R ;
Slater, NKH .
BIOTECHNOLOGY PROGRESS, 2004, 20 (04) :1113-1120